m+Medelevator.RU
← Поиск публикаций
Transplantation · 2021

Characteristics of T- and NK-cell Lymphomas After Renal Transplantation: A French National Multicentric Cohort Study.

СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Barba Thomas, Bachy Emmanuel, Maarek Alizée, Fossard Gaëlle, Genestier Laurent, Anglicheau Dany, Moal Valérie, Dantal Jacques, Rieu Philippe, Chemouny Jonathan, Charrier Manon, Durrbach Antoine, Provot François, Ducloux Didier, Westeel Pierre-François, Heng Anne-Elisabeth, Rerolle Jean-Philippe, Barrou Benoit, Grimbert Philippe, Chatelet Valérie, Mousson Christiane, Janbon Bénédicte, Pernin Vincent, Frimat Luc, Ouali Nacera, Glotz Denis, Thierry Antoine, Mariat Christophe, Büchler Mathias, Gaulard Philippe, Leblond Véronique, Morelon Emmanuel, Dubois Valérie, Salles Gilles, Caillard Sophie, Thaunat Olivier

Аннотация

BACKGROUND: Posttransplant lymphoproliferative disorders (PTLDs) encompass a spectrum of heterogeneous entities. Because the vast majority of cases PTLD arise from B cells, available data on PTLD of T or NK phenotype (T/NK-cell PTLD) are scarce, which limits the quality of the management of these patients.

METHODS: All adult cases of PTLD diagnosed in France were prospectively recorded in the national registry between 1998 and 2007. Crosschecking the registry data with 2 other independent national databases identified 58 cases of T/NK-cell PTLD. This cohort was then compared with (i) the 395 cases of B-cell PTLD from the registry, and of (ii) a cohort of 148 T/NK-cell lymphomas diagnosed in nontransplanted patients.

RESULTS: T/NK-cell PTLD occurred significantly later after transplantation and had a worse overall survival than B-cell PTLD. Two subtypes of T/NK-cell PTLD were distinguished: (i) cutaneous (28%) and (ii) systemic (72%), the latter being associated with a worse prognosis. Compared with T/NK-cell lymphomas of nontransplanted patients, overall survival of systemic T/NK-cell PTLD was worse (hazard ratio: 2.64 [1.76-3.94]; P < 0.00001).

CONCLUSIONS: This difference, which persisted after adjustment on tumoral mass, histological subtype, and extension of the disease at diagnosis could be explained by the fact that transplanted patients were less intensively treated and responded less to chemotherapy.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты